临床肝胆病杂志2025，Vol.41Issue(8)：1481-1486,6.DOI:10.12449/JCH250801
肝细胞癌治疗新进展
The latest advances in the treatment of hepatocellular carcinoma
摘要
Abstract
Hepatocellular carcinoma(HCC)is a severely detrimental global public health issue,and its incidence and mortality rates remain at a high level.According to the data from the World Health Organization,there were 866 000 new cases of HCC and 759 000 deaths worldwide in 2022,and it is predicted that by 2040,there will be significant increases in the numbers of new cases and deaths due to HCC.In the face of these great challenges,significant advances have been made in the diagnosis and treatment of HCC in recent years,and from the improvements in traditional surgeries and local treatment to groundbreaking innovations in targeted therapy and immunotherapy and the application of the concept of precision medicine,various treatment methods have provided more treatment options and survival opportunities for patients with different stages.This article reviews the advances in the treatment of HCC and analyzes current therapeutic difficulties and future development directions,in order to provide a reference for clinical practice and academic research.关键词
癌,肝细胞/肝切除术/分子靶向治疗/免疫疗法Key words
Carcinoma,Hepatocellular/Hepatectomy/Molecular Targeted Therapy/Immunotherapy引用本文复制引用
周俭,黄晓勇..肝细胞癌治疗新进展[J].临床肝胆病杂志,2025,41(8):1481-1486,6.基金项目
国家自然科学基金(82273234) （82273234）
上海市自然科学基金(21ZR1412200) （21ZR1412200）
